We have a solution for everything – and the corresponding experience. In our current seven areas of expertise, we are at your disposal with our comprehensive know-how.

All Solutions

Software solutions

Software solutions

With our Werum PAS-X MES - on premise or cloud-based - and our software solutions for analysis, track & trace, networked factories, and intelligent packaging, we are the world's leading supplier and partner to the pharmaceutical and biotech industries.

Overview Software solutions

Handling systems

Handling systems

We are specialists for complete handling systems for pharmaceutical and medical products. Our solutions are decisive in the field of contactless and safe transport of e.g. glass syringes.

Overview Handling systems

Inspection machines


As the world's leading inspection expert, we develop solutions for the pharmaceutical and biotech industries. Our range of products extends from high-performance machines and semi-automatic machines to laboratory units and inspection applications for in-process control.

Overview Inspection

Machine finder

Packaging machines

Packaging machines

We are a leading supplier of packaging machines for liquid and solid pharmaceutical and medical products. With our blister, sachet and stick packaging machines we offer solutions for primary packaging. Our side and topload cartoners set standards worldwide for secondary packaging.

Overview Packaging machines

K.Pak Topload Case Packer

Introducing our latest solution from Körber; the K.Pak Topload Case Packer! Created specifically for the pharmaceutical industry, the K.Pak solution provides operator-friendly machines to complete any production line. Our solution focuses on innovative technology, high-quality design and expert handling and packaging of your product. It’s time to start connecting the dots with Körber!

Packaging solutions

Packaging solutions

As long-standing specialists, we develop packaging solutions for innovative and high-quality secondary pharmaceutical packaging made of cardboard. We offer you solutions for counterfeit protection, standard folding boxes and much more.

Overview Packaging solutions



Our experts will advise you during the analysis of your requirements, show you optimisation potential and support you during the implementation of projects in all areas of the pharmaceutical, biotech and medical device industry.

Overview Consulting


Regulatory information management: Why we believe in IDMP and you should too

The EMA will be delaying the roll-out of the new ISO IDMP (Identification of Medicinal Products) standard within Europe until after the completion of the formal Brexit processes. And yes, so far no EU Implementation Guidelines have been published and there is no need to start submitting product data and regulatory information in the new format. But whether you were skeptical about the original implementation deadlines or not, one thing remains – IDMP will still happen, with or without Brexit!

So how should you react? Is this a time to relax and enjoy some spare cycles in your day? Or is this your opportunity to be proactive and push forward with your plans knowing that IDMP is not only about regulatory standards, but also a significant opportunity for your business to improve its own internal data handling processes?

The choice is yours, but with so much to be gained these are our top five reasons for continuing at pace with your IDMP roll-out:

  1. Set your data free and let it breathe
    With so much data locked away in documents and other unstructured content, now is the time to set it free. Finding and extracting that data, then storing it into a place where you can manage it in a controlled and structured fashion will not only make your processes more efficient, but it will also help you to understand what your business already knows.
  2. Improve the quality of your existing XEVMPD data
    XEVMPD (eXtended Eudra Vigilance Medicinal Product Dictionary) is the first step towards IDMP. If you can manage your data well in XEVMPD format, then when the day to migrate to IDMP finally arrives you will already be able to understand and consume the new, additional, information.
  3. Introduce smart business processes
    In the past many business processes have been introduced in reaction to something bad that has happened. This breathing space means that you can now turn things around and perform a proactive review of your processes. By starting to think now about where IDMP data will touch your processes you can make sure that it is accessible, clean and ready to use before the guidelines arrive.
  4. Eliminate inefficiencies and increase transparency
    Across the industry we have enough duplicate data to fill a canyon. Now is our opportunity to slim that down and remove inefficiencies in our data capture, storage and reporting processes. By better understanding the underlying data we can more quickly answer common questions, such as “How many registrations do we have?” and “What does this drug treat?”
  5. Use the time you have been given productively
    By nature we’re all the same. Given extra time to do something we all leave it to the bitter end and then rush to complete an average job, exactly on the given deadline. By delaying IDMP within Europe, the EMA has given us all an opportunity to get ahead of the curve. We know what is coming so we should use that time to move forward with plans, implement new processes and learn from mistakes before those errors cost us in real money through fines and lost revenue.

At the end of the day the new European pharmacovigilance legislation may be driving our actions, but there are so many more benefits beyond just compliance. We are talking about things such as control over information, key performance indicators and powering-up your workforce. We are talking about reusing what has already been done. We are talking about saving time and money by reducing time-to-market. And we are talking about increasing efficiencies by merging together the worlds of regulatory affairs, pharmacovigilance, manufacturing and clinical into a single managed solution.

How to go ahead with IDMP now? Waiting for further advice from EMA, or acting according to the principles of the IDMP architects?

Our recommendation is to stay on your pathway to IDMP but to shift your focus from “How to become IDMP compliant?” to “How can we gain more efficiency, how can we achieve effortless compliance and how can we get IDMP compliant while not needing to think about IDMP compliance?”

For more information on IDMP technologies, best practices and implementation approaches come and talk with us at EXTEDO. We will ensure that when the day finally arrives you are ready to hit the IDMP road running!


No comments

Write comment

* These fields are required

Back to top
Back to top